Skip to content

BLLN

BillionToOne, Inc.

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$99.39
−0.11%
Ask drillr

Income statement

MetricTTM202520242023
Revenue
Total Revenue397.4M305.1M152.6M71.7M
Cost of Revenue114.2M96.7M71.7M54.4M
Gross Profit283.2M208.5M80.9M17.3M
Operating Expenses
R&D Expense59.2M49.4M36.6M22.4M
SG&A Expense180.7M143.1M91.5M64.4M
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses239.9M192.4M128.1M86.8M
Cost and Expenses354.1M289.1M199.7M141.2M
Operating Income (EBIT)43.3M16.0M(47.1M)(69.5M)
Non-Operating
Interest Income14.1M7.8M5.8M3.5M
Interest Expense41.0K95.0K2.4M3.3M
Net Interest Income14.1M7.7M3.4M184.0K
Other Non-Op Income/Expense(5.4M)(8.3M)5.6M(13.2M)
Non-Operating Income (excl Interest)5.4M8.2M(8.0M)9.9M
EBT (Pre-Tax Income)37.9M7.8M(41.5M)(82.7M)
Income Tax Expense194.0K305.0K29.0K9.0K
Bottom Line
Net Income33.5M7.5M(41.6M)(82.7M)
Earnings from Cont. Ops37.7M7.5M(41.6M)(82.7M)
Earnings from Discont. Ops
Bottom Line Net Income31.9M2.9M(41.6M)(82.7M)
Per Share
Basic EPS$0.69$0.06($0.93)($1.85)
Diluted EPS$0.62$0.06($0.93)($1.85)
Revenue Per Share$8.56$6.66$3.41$1.60
Shares
Basic Shares Outstanding46.4M45.8M44.7M44.7M
Diluted Shares Outstanding54.5M45.8M44.7M44.7M
Profitability Metrics
EBITDA50.2M19.8M(27.5M)(72.9M)
D&A12.3M11.9M11.7M6.5M
EBIT37.9M7.9M(39.2M)(79.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026